microRNA-155 is downregulated in gastric cancer cells and involved in cell metastasis

Oncology Reports

Volumn 27, Issue 6, 2012, Pages 1960-1966

  Li, Cheng Long ^a   Nie, Hui ^a,b   Wang, Ming ^a   Su, Li Ping ^a   Li, Jian Fang ^a   Yu, Ying Yan ^a   Yan, Min ^a   Qu, Qin Long ^a   Zhu, Zheng Gang ^a   Liu, Bing Ya ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

DNA methylation; Gastric cancer; Metastasis; microRNA 155; SMAD2

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; LUCIFERASE; MICRORNA 155; SMAD2 PROTEIN;

3' UNTRANSLATED REGION; ARTICLE; BINDING SITE; CANCER CELL; CELL ADHESION; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; DNA METHYLATION; DOWN REGULATION; EMBRYO; ENZYME ACTIVITY; EPITHELIUM CELL; GENE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; IN VITRO STUDY; METASTASIS; PRIORITY JOURNAL; PROTEIN RNA BINDING; SMAD FAMILY MEMBER 2 GENE; STOMACH CANCER; STOMACH EPITHELIUM;

3' UNTRANSLATED REGIONS; AZACITIDINE; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DNA METHYLATION; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HEK293 CELLS; HUMANS; MICRORNAS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; SMAD2 PROTEIN; STOMACH NEOPLASMS;

EID: 84860732927     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.1719     Document Type: Article

References (35)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
2. Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM: GLOBOCAN 2008 v1.2, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10. Lyon. International Agency for Research on Cancer; Available from: http://globocan.iarc.fr. Last accessed 9/16/2011, 2010.
3. Moon YW, Jeung HC, Rha SY, et al: Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: a 15-year follow-up study at a single Korean institute. Ann Surg Oncol 14: 2730-2737, 2007. (Pubitemid 47460643)
4. Bartel DP: microRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297, 2004.
5. Bartel DP: microRNAs: target recognition and regulatory functions. Cell 136: 215-233, 2009.
6. Munker R and Calin GA: microRNA profiling in cancer. Clin Sci (Lond) 121: 141-158, 2011.
7. Farazi TA, Spitzer JI, Morozov P and Tuschl T: miRNAs in human cancer. J Pathol 223: 102-115, 2011.
8. Di Leva G and Croce CM: Roles of small RNAs in tumor formation. Trends Mol Med 16: 257-267, 2010.
9. Lagos-Quintana M, Rauhut R, Yalcin A, Meyer J, Lendeckel W and Tuschl T: Identification of tissue-specific microRNAs from mouse. Curr Biol 12: 735-739, 2002. (Pubitemid 34455427)
10. Faraoni I, Antonetti FR, Cardone J and Bonmassar E: miR-155 gene: a typical multifunctional microRNA. Biochim Biophys Acta 1792: 497-505, 2009.
11. Tili E, Croce CM and Michaille JJ: miR-155: on the crosstalk between inflammation and cancer. Int Rev Immunol 28: 264-284, 2009.
12. Iorio MV, Ferracin M, Liu CG, et al: MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65: 7065-7070, 2005. (Pubitemid 41161233)
13. Lee EJ, Gusev Y, Jiang J, et al: Expression profiling identifies microRNA signature in pancreatic cancer. Int J Cancer 120: 1046-1054, 2007. (Pubitemid 46214304)
14. Bandres E, Cubedo E, Agirre X, et al: Identification by real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol Cancer 5: 29, 2006.
15. Nikiforova MN, Tseng GC, Steward D, Diorio D and Nikiforov YE: microRNA expression profiling of thyroid tumors: biological significance and diagnostic utility. J Clin Endocrinol Metab 93: 1600-1608, 2008. (Pubitemid 351656494)
16. Wang X, Tang S, Le SY, et al: Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth. PLoS One 3: e2557, 2008.
17. Yanaihara N, Caplen N, Bowman E, et al: Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9: 189-198, 2006. (Pubitemid 43357945)
18. Donnem T, Eklo K, Berg T, et al: Prognostic impact of MiR-155 in non-small cell lung cancer evaluated by in situ hybridization. J Transl Med 9: 6, 2011.
19. Dorsett Y, McBride KM, Jankovic M, et al: MicroRNA-155 suppresses activation-induced cytidine deaminase-mediated Myc-Igh translocation. Immunity 28: 630-638, 2008.
20. Levati L, Pagani E, Romani S, et al: microRNA-155 targets the SKI gene in human melanoma cell lines. Pigment Cell Melanoma Res 24: 538-550, 2011.
21. Levati L, Alvino E, Pagani E, et al: Altered expression of selected microRNAs in melanoma: antiproliferative and proapoptotic activity of miRNA-155. Int J Oncol 35: 393-400, 2009.
22. Chen XM, Splinter PL, O'Hara SP and LaRusso NF: A cellular micro-RNA, let-7i, regulates Toll-like receptor 4 expression and contributes to cholangiocyte immune responses against Cryptosporidium parvum infection. J Biol Chem 282: 28929-28938, 2007. (Pubitemid 47610421)
23. Louafi F, Martinez-Nunez RT and Sanchez-Elsner T: MicroRNA-155 targets SMAD2 and modulates the response of macrophages to transforming growth factor-β. J Biol Chem 285: 41328-41336, 2010.
24. Calin GA and Croce CM: microRNA signatures in human cancers. Nat Rev Cancer 6: 857-866, 2006. (Pubitemid 44629897)
25. Kluiver J, Haralambieva E, de Jong D, et al: Lack of BIC and microRNA miR-155 expression in primary cases of Burkitt lymphoma. Genes Chromosomes Cancer 45: 147-153, 2006. (Pubitemid 43191021)
26. Roldo C, Missiaglia E, Hagan JP, et al: microRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. J Clin Oncol 24: 4677-4684, 2006. (Pubitemid 46630931)
27. Dahiya N, Sherman-Baust CA, Wang TL, et al: microRNA expression and identification of putative miRNA targets in ovarian cancer. PLoS One 3: e2436, 2008.
28. Wald AI, Hoskins EE, Wells SI, Ferris RL and Khan SA: Alteration of microRNA profiles in squamous cell carcinoma of the head and neck cell lines by human papillomavirus. Head Neck 33: 504-512, 2011.
29. Imig J, Motsch N, Zhu JY, et al: microRNA profiling in Epstein-Barr virus-associated B-cell lymphoma. Nucleic Acids Res 39: 1880-1893, 2011.
30. Miyazono K, Suzuki H and Imamura T: Regulation of TGF-beta signaling and its roles in progression of tumors. Cancer Sci 94: 230-234, 2003. (Pubitemid 36575887)
31. Derynck R, Akhurst RJ and Balmain A: TGF-beta signaling in tumor suppression and cancer progression. Nat Genet 29: 117-129, 2001. (Pubitemid 32952643)
32. Bruna A, Darken RS, Rojo F, et al: High TGFbeta-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene. Cancer Cell 11: 147-160, 2007. (Pubitemid 46209848)
33. Oft M, Akhurst RJ and Balmain A: Metastasis is driven by sequential elevation of H-ras and Smad2 levels. Nat Cell Biol 4: 487-494, 2002. (Pubitemid 34752433)
34. Shinto O, Yashiro M, Toyokawa T, et al: Phosphorylated smad2 in advanced stage gastric carcinoma. BMC Cancer 10: 652, 2010.
35. van den Berg A, Kroesen BJ, Kooistra K, et al: High expression of B-cell receptor inducible gene BIC in all subtypes of Hodgkin lymphoma. Genes Chromosomes Cancer 37: 20-28, 2003. (Pubitemid 36417918)